Cargando…
What radiolabeled FAPI pet can add in breast cancer? A systematic review from literature
To provide an overview of the current available data about FAPI PET in breast cancer patients, with a perspective point of view. A literature search for studies about FAPI PET in the last 5 years (from 2017 to January 2023) was carried out on MEDLINE databases, such as PubMed, EMBASE, Web of Science...
Autores principales: | Evangelista, Laura, Filippi, Luca, Schillaci, Orazio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345025/ https://www.ncbi.nlm.nih.gov/pubmed/37341971 http://dx.doi.org/10.1007/s12149-023-01852-x |
Ejemplares similares
-
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature
por: Guglielmo, Priscilla, et al.
Publicado: (2023) -
[(18)F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review
por: Filippi, Luca, et al.
Publicado: (2023) -
Clinical Applications of TSPO PET for Glioma Imaging: Current Evidence and Future Perspective—A Systematic Review
por: Filippi, Luca, et al.
Publicado: (2023) -
(68)Ga- or (18)F-FAPI PET/CT—what it can and cannot
por: Mori, Yuriko, et al.
Publicado: (2023) -
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics—Where We Are at and Where We Are Heading: A Systematic Review
por: Sidrak, Marko Magdi Abdou, et al.
Publicado: (2023)